Francis W. Price

Dr. Francis W. Price


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2005 in Journal of Refractive Surgery
Verified
Journal Article
Closed access
PDF file
FPFrancis W. Price
Francis W. Price
MPMarianne O Price
Marianne O Price
PURPOSE: To evaluate early visual and refractive outcomes following treatment of corneal endothelial dysfunction with a corneal transplantation technique, Descemet's stripping with endothelial keratoplasty (DSEK). METHODS: Visual and refractive outcomes of the first 50 consecutive cases of DSEK performed by a single surgeon between December 2003 and July 2004 were analyzed retrospectively. The DSEK technique consisted of stripping Descemet's membrane and endothelium from a recipient cornea and transplanting the posterior stroma and endothelium of a donor cornea through a 5-mm incision. RESULTS: Results are reported for 50 eyes in 47 patients (30 women and 17 men). Mean patient age at surgery was 70±12 years (range: 34 to 89 years). Five eyes were treated for corneal edema or bullous keratopathy and 45 for Fuchs' endothelial dystrophy. Seven eyes were phakic and 43 were Pseudophakic. Six months after surgery, mean manifest cylinder was 1.5±0.94 diopters (D), unchanged from preoperative cylinder of 1.5±1.0 D. Mean manifest spherical equivalent refraction was 0.15 ±1.5 D at 6-month follow-up compared with -0.36±1.4 D preoperatively (P=.10) At 3- and 6-month follow-up, significant improvement was noted in mean best spectacle-corrected visual acuity compared with the preoperative mean of 20/100 (P=.007). At 6-month follow-up, 31 (62%) eyes refracted to ≥20/40 and 38 (76%) eyes saw ≥20/50. CONCLUSIONS: Compared to standard penetrating keratoplasty, DSEK causes minimal refractive change and provides rapid visual recovery for patients with endothelial dysfunction. This technique maintains the structural integrity of the cornea by preserving the recipient's epithelium, Bowman's layer, and entire stromal thickness. [J Refract Surg. 2005;21:339-345.]

1 July 2007 in Current Opinion in Ophthalmology
Verified
Journal Article
Closed access
MPMarianne Price
Marianne Price
FPFrancis W. Price
Francis W. Price
Descemet's stripping endothelial keratoplasty (DSEK) is rapidly becoming the preferred treatment for corneal endothelial dysfunction. Familiarity with recent advances in techniques and instrumentation can help reduce the initially steep learning curve and incidence of complications. DSEK produces excellent visual outcomes with minimal change in corneal surface topography or refraction. It can successfully treat corneal dysfunction associated with Fuchs' endothelial dystrophy, bullous keratopathy, iridocorneal endothelial syndrome or a failed penetrating graft. Donor dissection has become automated, and new techniques have been devised to facilitate graft insertion and unfolding. Some surgeons now routinely perform DSEK with topical anesthesia. Graft detachment is the most frequent early postoperative complication, but new methods can help promote donor adherence. The incidence of graft-rejection episodes is lower after DSEK compared with standard penetrating keratoplasty, possibly because wound healing is a lesser concern, and many DSEK patients are maintained on low-dose topical steroids indefinitely. Early efforts to transplant just the endothelial cell layer show promise. DSEK provides quicker visual rehabilitation and an improved safety profile compared with standard penetrating keratoplasty. Continued evolution of this relatively new technique is helping to reduce complications and further improve outcomes.

1 September 2006 in Cornea
Verified
Journal Article
Closed access
FPFrancis W. Price
Francis W. Price
MPMarianne Price
Marianne Price
Purpose: To describe an adaptation of endothelial keratoplasty to restore corneal clarity to a prior penetrating keratoplasty (PK) with endothelial decompensation. Methods: A surgeon’s initial 7 consecutive cases using endothelial keratoplasty for treatment of failed prior PK were retrospectively analyzed. The treated eyes had all experienced endothelial decompensation after previously having clear corneal transplants. Instead of repeating the PK, a partial-thickness donor button, composed of posterior stroma with Descemet membrane and endothelium, was grafted to the posterior surface of the failed full-thickness donor graft. In 6 of the 7 cases, the only sutures were those used to close a 5-mm scleral tunnel incision. The donor button was initially held in place with an air bubble and later attached on its own. Results: In all cases, the new donor button adhered to and cleared the edema from the previous penetrating graft. Within 3 months of endothelial keratoplasty, best-corrected visual acuity had improved in 6 of the 7 cases compared with the preoperative vision. Conclusion: Standard PK usually takes months to years to heal sufficiently to remove sutures and provide patients with a stable refraction and a wound strong enough to withstand minor trauma. Using endothelial keratoplasty to rehabilitate a failed graft may provide faster visual recovery, a tectonically stronger eye, and a reduced period of disability compared with repeating the PK. Endothelial keratoplasty may be a particularly useful alternative for treating penetrating grafts that achieved acceptable refractive and ocular surface results but failed because of endothelial dysfunction.

15 September 2017 in Annual Review of Vision Science
Verified
Journal Article
Closed access
MPMarianne Price
Marianne Price
PGPankaj Gupta
Pankaj Gupta
JLJonathan Lass
Jonathan Lass
FPFrancis W. Price
Francis W. Price
Endothelial keratoplasty (EK) has revolutionized treatment of corneal endothelial dysfunction. Compared with penetrating keratoplasty (PK), EK provides faster and more reliable visual rehabilitation while maintaining the eye's structural integrity. The number of EK procedures is growing annually and surpassed PK in the United States in 2012. The most widely used iteration, Descemet stripping endothelial keratoplasty (DSEK), implants healthy donor endothelium, Descemet membrane, and posterior stroma. Descemet membrane endothelial keratoplasty (DMEK) eliminates the donor stromal layer. Although more surgically challenging than DSEK, DMEK provides even faster visual rehabilitation and reduced risk of immunologic rejection, so its use is growing. Potential future alternatives to EK that could help address the unmet demand for donor corneas include removing central guttae and regenerating a central endothelial cell layer from healthy peripheral cells in patients with Fuchs’ dystrophy or injecting cultured human corneal endothelial cells to rehabilitate eyes without residual healthy endothelium.

21 October 2004 in Current Medical Research and Opinion
Verified
Journal Article
Closed access
MPMarianne Price
Marianne Price
FPFrancis W. Price
Francis W. Price
SUMMARYObjective: To evaluate the efficacy of ketorolac 0.4% ophthalmic solution for control of pain and discomfort associated with cataract surgery.Methods: This was a single-center, double-masked, randomized, fellow-eye placebo-controlled clinical study of 25 patients (mean age 72 years; 76% female) requiring bilateral cataract surgery. Patients received either ketorolac tromethamine 0.4% ophthalmic solution (Acular LS*) or placebo, 1 drop QID for 3 days prior to and 1 day following phacoemulsification and intraocular lens implantation on their first eye, and the other treatment for surgery on the second, fellow eye 1 week–4 weeks later. The physician rated patient cooperation and ocular pain or discomfort during surgery, and patients rated ocular pain or discomfort immediately and 24 h after surgery.Results: Patients reported significantly less ocular pain during the 24 h following surgery when treated with ketorolac 0.4% than with placebo ( p = 0.02). Ocular pain was reported for only a single ketorol...

1 March 2005 in Ophthalmology
Verified
Journal Article
Closed access
FPFrancis W. Price
Francis W. Price
RMRichard J. Mackool
Richard J. Mackool
KMKevin M. Miller
Kevin M. Miller
PKPaul Koch
Paul Koch
TOThomas A. Oetting
Thomas A. Oetting
AJA. Tim Johnson
A. Tim Johnson